508
Views
6
CrossRef citations to date
0
Altmetric
Articles

Effects of amnion derived mesenchymal stem cells on fibrosis in a 5/6 nephrectomy model in rats

, , , , , , , & ORCID Icon show all

References

  • Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP. 2007. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 21:11.
  • Anderson S, Meyer TW, Rennke HG, Brenner BM. 1985. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 76:612–619.
  • Asanuma H, Vanderbrink BA, Campbell MT, Hile KL, Zhang H, Meldrum DR. 2011. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res. 168:e51–e59.
  • Bottinger EP, Bitzer M. 2002. TGF-β signaling in renal disease. J Am Soc Nephrol, 13:2600−2610.
  • Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res. 9:641–650.
  • Cavaglieri RC, Martini D, Sogayar MC, Noronha IL. 2009. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transpl Proc. 41:947–951.
  • Cetinkaya B, Unek G, Kipmen-Korgun D, Koksoy S, Korgun ET. 2018. Effects of human placental amnion derived mesenchymal stem cells on proliferation and apoptosis mechanisms in chronic kidney disease in the rat. Int J Stem Cells. 12:151–161.
  • Choi S, Park M, Kim J, Hwang S, Park S, Lee Y. 2009. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 18:521–529.
  • Choi SJ, Kim JK, Hwang SD. 2010. Mesenchymal stem cell therapy for chronic renal failure. Exp Opin Biol Ther. 10:1217–1226.
  • Da Silva AF, Silva K, Reis LA, Teixeira VP, Schor N. 2015. Bone marrow-derived mesenchymal stem cells and their conditioned medium attenuate fibrosis in an irreversible model of unilateral ureteral obstruction. Cell Transpl. 24:2657–2666.
  • Díaz-Prado S, Muiños-López E, Hermida-Gómez T, Rendal-Vázquez ME, Fuentes-Boquete I, de Toro FJ, Blanco FJ. 2010. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J Cell Biochem. 111:846–857.
  • Eddy AA. 1996. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol. 7:2495–2508.
  • Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, Islam N, Bravo RF, Aleckovic-Halilovic M, Zou H, Zhang L, Gouda Z, Tchokhonelidze I, Abraham G, Mahdavi-Mazdeh M, Gallieni M, Codreanu I, Togtokh A, Sharma SK, Koirala P, Uprety S, Ulasi I, Remuzzi G. 2016. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 4:e307–e319.
  • Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, Camussi G. 2011. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 26:1474–1483.
  • Gould SE, Day M, Jones SS, Dorai H. 2002. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidn Int. 61:51–60.
  • Hay ED. 2005. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 233:706–720.
  • Hopkins C, Li J, Rae F, Little MH. 2009. Stem cell options for kidney disease. J Pathol. 217:265–281.
  • Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. 1981. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 241:85–93.
  • Imai N, Kaur T, Rosenberg ME, Gupta S. 2009. Cellular therapy of kidney diseases. Sem Dial. 22:629–635.
  • In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-swings GM, Claas FH, Fibbe WE, Kanhai HH. 2004. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 22:1338–1345.
  • Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. 2017. Chronic kidney disease: global dimension and perspectives. Lancet. 390:1888–1917.
  • Jiang F, Zhang W, Zhou M, Zhou Z, Shen M, Chen N, Jiang X. 2020. Human amniotic mesenchymal stromal cells promote bone regeneration via activating endogenous regeneration. Theranostics. 10:6216–6230.
  • Junqueira LC, Bignolas G, Brentani RR. 1979. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 11:447–455.
  • Karavanova ID, Dove LF, Resau JH, Perantoni AO. 1996. Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme. Development. 122:4159–4167.
  • Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J. 1996. Mechanisms involved in the pathogenesis of tubule-interstitial fibrosis in 5/6-nephrectomized rats. Kidn Int. 49:666–678.
  • Konige M, Wang H, Sztalryd C. 2013. Role of adipose specific lipid droplet proteins in maintaining whole body energy homeostasis. Biochim Biophys Acta. 1842:393–401.
  • Korgun ET, Celik-Ozenci C, Seval Y, Desoye G, Demir R. 2005. Do glucose transporters have other roles in addition to placental glucose transport during early pregnancy? Histochem Cell Biol. 123:621–629.
  • Lange C, Tögel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C. 2005. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidn Int. 68:1613–1617.
  • Little MH. 2006. Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol. 17:2390–2401.
  • Liu Y. 2004. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 15:1–12.
  • Liu Y. 2011. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 7:684–696.
  • Loboda A, Sobczak M, Jozkowicz A, Dulak J. 2016. TGF-β1/Smads and miR-21 in renal fibrosis and inflammation. Mediat Inflam. 2016:8319283.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
  • Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M. 2004. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol. 15:1277–1288.
  • Mohamad-Fauzi N, Ross PJ, Maga EA, Murray JD. 2015. Impact of source tissue and ex vivo expansion on the characterization of goat mesenchymal stem cells. J Anim Sci Biotechnol. 6:1–22.
  • Noronha IL, Fujihara CK, Zatz R. 2002. The inflammatory component in progressive renal disease–are interventions possible? Nephrol Dial Transpl. 17:363–368.
  • Ozmen A, Unek G, Kipmen-Korgun D, Korgun ET. 2011. The expression of Akt and ERK1/2 proteins decreased in dexamethasone-induced intrauterine growth restricted rat placental development. J Mol Histol. 42:237–249.
  • Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC. 2008. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells. 26:300–311.
  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multi-lineage potential of adult human mesenchymal stem cells. Science. 284:143–147.
  • Puchtler H, Waldrop FS, Valentine LS. 1973. Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitr Pathol. 150:174–187.
  • Romagnani P, Kalluri R. 2009. Possible mechanisms of kidney repair. Fibrogen Tissue Rep. 2:3.
  • Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia Dos Reis M, Shimizu MH, Seguro AC, Pacheco-Silva A, Saraiva Camara NO. 2009. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells. 27:3063–3073.
  • Skromne I, Stern CD. 2001. Interactions between Wnt and Vg1 signalling pathways initiate primitive streak formation in the chick embryo. Development. 128:2915–2927.
  • Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altiparmak MR, Ecder T, Yilmaz ME, Çamsari T, Başçi A. 2010. A population-based survey of chronic renal disease in Turkey—the CREDIT study. Nephrol Dial Transpl. 26:1862–1871.
  • Sun D, Bu L, Liu C, Yin Z, Zhou X, Li X, Xiao A. 2013. Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction. PLoS One. 8:e65042.
  • Thiery JP. 2002. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer. 2:442–454.
  • Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 7:131–142.
  • Tullberg-Reinert H, Jundt G. 1999. In situ measurement of collagen synthesis by human bone cells with a Sirius red-based colorimetric microassay: effects of transforming growth factor beta-2 and ascorbic acid 2-phosphate. Histochem Cell Biol. 112:271–276.
  • Ueno T, Nakashima A, Doi S, Kawamoto T, Honda K, Yokoyama Y, Doi T, Higashi Y, Yorioka N, Kato Y, Kohno N, Masaki T. 2013. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidn Int. 84:297–307.
  • Unek G, Cetinkaya B, Dogru DK, Molbay M, Ozmen A, Yanar K, Korgun- Kipmen D, Koksoy S, Sakinci M, Korgun ET. 2020. Expression of glucose transporters in the human amnion derived mesenchymal stromal cells under normoglycemic and hyperglycemic conditions. Biologia. 75:299–308.
  • van Koppen A, Joles JA, van Balkom BW, Lim SK, de Kleijn D, Giles RH, Verhaar MC. 2012. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One. 7:e38746.
  • Vellasamy S, Sandrasaigaran P, Vidyadaran S, George E, Ramasamy R. 2012. Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World J Stem Cells. 4:53–61.
  • Villanueva S, Ewertz E, Carrión F, Tapia A, Vergara C, Céspedes C, Sáez PJ, Luz P, Irarrázabal C, Carreño JE, Figueroa F, Vio CP. 2011. Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model. Clin Sci (Lond). 121:489–499.
  • Wang S, Li Y, Zhao J, Zhang J, Huang Y. 2013. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol Blood Marrow Transpl. 19:538–546.
  • Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I. 1989. Effects of antihypertensive drugs on glomerular morphology. Kidney Int. 36:626–635.
  • Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. 2003. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 9:964–968.
  • Zhang J, Yun S, Bi J, Dai S, Du Y, Zannettino ACW, Zhang H. 2018. Enhanced multi-lineage differentiation of human mesenchymal stem/stromal cells within poly(N-isopropylacrylamide-acrylic acid) microgel-formed three-dimensional constructs. J Mater Chem B. 6:1799–1814.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.